With the first da Vinci prostatectomy in 2000, urologic surgeons began creating a deep legacy of continuous innovation and collaboration with Intuitive. That legacy generated a track record of positive clinical outcomes through a shared and long-standing belief in robotic urologic surgery.
Today, the evolving needs of urologic surgeons still inspire our drive to innovate beyond multiport robotics. See how the da Vinci SP surgical system enabled single-site entry at different access points in prostatectomy and nephrectomy cases performed by Drs. Kaouk, Ahmed, and Nelson. Also, watch how Dr. Stifelman used the capabilities of the da Vinci Xi surgical system to accomplish a partial nephrectomy.
View our webinars for peer-to-peer learning dedicated to the innovative spirit of urologic surgeons and their journeys with robotics. Hear directly from other surgeons about their experiences with the comprehensive Intuitive ecosystem of systems, learning, services, and digital insights.
Get the latest tips on techniques, expanding your practice, and building programs. Topics include surgeons’ experiences with incorporating both da Vinci Xi and SP into a practice, choosing the right da Vinci system for prostatectomy or nephrectomy, and progressing through the da Vinci SP learning curve.
Important safety information
Serious complications may occur in any surgery, including da Vinci surgery, up to and including death. Serious risks include, but are not limited to, injury to tissues and organs and conversion to other surgical techniques which could result in a longer operative time and/or increased complications. For summary of the risks associated with surgery refer to www.intuitive.com/safety.
For product intended use and/or indications for use, risks, cautions, and warnings and full prescribing information, refer to the associated user manual(s) or visit https://manuals.intuitivesurgical.com/market
Individual outcomes may depend on a number of factors—including but not limited to—patient characteristics, disease characteristics, and/or surgeon experience.
Da Vinci SP system
The safety and effectiveness of this device for use in the performance of general laparoscopic surgery procedures have not been established. This device is only intended to be used for single port urological and general thoracoscopic surgical procedures and for transoral otolaryngology surgical procedures in the oropharynx for benign tumors and malignant tumors classified as T1 and T2 with the da Vinci EndoWrist SP Instruments and the da Vinci SP Surgical System (SP1098).
Da Vinci Xi/X system
The demonstration of safety and effectiveness for the representative specific procedures did not include evaluation of outcomes related to the treatment of cancer (overall survival, disease-free survival, local recurrence), except for radical prostatectomy which was evaluated for overall survival, or treatment of the patient’s underlying disease/condition. Device usage in all surgical procedures should be guided by the clinical judgment of an adequately trained surgeon.